TagsMavorixafor

Tag: Mavorixafor

Healthcare

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

Ravindra Soni - January 25, 2025 0

Most Read

Doodhvale Farms wins Emerging D2C Dairy Protein Brand at The India Collective

November 3, 2026

NSN Mohan elected first Indian SKÅL International World President for 2027

November 3, 2026

Wintermar Offshore Q3 profit surges 67.6% on higher vessel margins

November 3, 2026

KLH Aziznagar Campus receives 3.5-star IIC rating for innovation initiatives

November 3, 2026

EDITOR PICKS

Doodhvale Farms wins Emerging D2C Dairy Protein Brand at The India Collective

November 3, 2026

NSN Mohan elected first Indian SKÅL International World President for 2027

November 3, 2026

Wintermar Offshore Q3 profit surges 67.6% on higher vessel margins

November 3, 2026

POPULAR POSTS

Doodhvale Farms wins Emerging D2C Dairy Protein Brand at The India Collective

November 3, 2026

NSN Mohan elected first Indian SKÅL International World President for 2027

November 3, 2026

Wintermar Offshore Q3 profit surges 67.6% on higher vessel margins

November 3, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.